An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)

Update Il y a 4 ans
Reference: NCT01697462

Woman and Man

  • | Country :
  • Serbia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This prospective observational study will evaluate the safety and efficacy of Xeloda (capecitabine) administered in monotherapy in patients with metastatic colorectal cancer. Patients will be followed until disease progression or unacceptable toxicity occurs.


Inclusion criteria

  • Colorectal Cancer

Links